Suppr超能文献

重组人蛋白C衍生物:对钙的反应改变,导致凝血酶激活增强。

Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin.

作者信息

Ehrlich H J, Grinnell B W, Jaskunas S R, Esmon C T, Yan S B, Bang N U

机构信息

Lilly Research Laboratories, Indianapolis, IN 46285.

出版信息

EMBO J. 1990 Aug;9(8):2367-73. doi: 10.1002/j.1460-2075.1990.tb07411.x.

Abstract

Calcium plays a dual role in the activation of protein C: it inhibits protein C activation by alpha-thrombin, whereas it is required for protein C activation by the thrombomodulin-thrombin complex. Available information suggests that these calcium effects are mediated through calcium induced structural changes in protein C. In this paper, we demonstrate that substitution of Asp167 (located in the activation peptide of human protein C, occupying position P3 relative to the peptide bond Arg169-Leu170 which is susceptible to hydrolysis by thrombin) by either Gly or Phe results in protein C derivatives which are characterized by an altered response to calcium. At 3 mM calcium, alpha-thrombin activated the derivatives 5- to 8-fold faster compared with the wild-type, an effect which was shown to be caused by a decreased inhibitory effect of calcium on the reaction. These same single amino acid substitutions enhanced the affinity of the thrombomodulin-thrombin complex for the substrate at 3 mM calcium 3-(Gly-substitution) to 6-(Phe-substitution) fold, either without influencing kcat (Gly-substitution) or with a 2.5-fold decrease of kcat. For both derivatives, the calcium concentrations resulting in half maximal inhibition of activation by alpha-thrombin and in half maximal stimulation of activation by the thrombomodulin-thrombin complex increased from 0.3 mM to 0.6 mM. It is concluded that Asp167 is involved in the calcium induced inhibition of protein C activation by thrombin. Moreover, our studies demonstrate that it is feasible to enhance the efficiency of enzymatic reactions by introducing point mutations in the substrate.

摘要

钙在蛋白C的激活过程中发挥着双重作用:它抑制α-凝血酶对蛋白C的激活,而它是血栓调节蛋白-凝血酶复合物激活蛋白C所必需的。现有信息表明,这些钙效应是通过钙诱导的蛋白C结构变化介导的。在本文中,我们证明将天冬氨酸167(位于人蛋白C的激活肽中,相对于易被凝血酶水解的肽键精氨酸169 - 亮氨酸170占据P3位置)替换为甘氨酸或苯丙氨酸会导致蛋白C衍生物对钙的反应发生改变。在3 mM钙浓度下,α-凝血酶激活衍生物的速度比野生型快5至8倍,这种效应被证明是由钙对反应的抑制作用降低所致。这些相同的单氨基酸替换在3 mM钙浓度下使血栓调节蛋白-凝血酶复合物对底物的亲和力提高了3倍(甘氨酸替换)至6倍(苯丙氨酸替换),要么不影响催化常数(kcat)(甘氨酸替换),要么使kcat降低2.5倍。对于这两种衍生物,导致α-凝血酶激活受到半数最大抑制和血栓调节蛋白-凝血酶复合物激活受到半数最大刺激的钙浓度从0.3 mM增加到了0.6 mM。结论是,天冬氨酸167参与了钙诱导的凝血酶对蛋白C激活的抑制作用。此外,我们的研究表明,通过在底物中引入点突变来提高酶促反应效率是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bac7/552260/c2b39e2f8da5/emboj00235-0024-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验